• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Clinilabs Boosts Phase I Capacity, Looks for More Growth

Clinilabs Boosts Phase I Capacity, Looks for More Growth

August 18, 2008
CenterWatch Staff

New York, N.Y.-based Clinilabs, a specialty contract research organization (CRO), has completed expansion of its phase I unit to 68 beds, including two new large observation rooms that can accommodate up to four beds each.

The company conducts phase I studies in any therapeutic area, including pharmacokinetic (PK), pharmacodynamic (PD), bioavailability (BA), bioequivalence (BE), drug interaction and food interaction studies.

Clinilabs also offers specialty services for complex PD studies, such as those that involve the collection of mood, cognition, psychomotor functioning, EEG, quantitative EEG, evoked potential and imaging data.

“Phase I studies are becoming increasingly complex, and sponsors depend on data from these studies to make crucial decisions about their development programs,” stated Dr. Gary Zammit, president and chief executive officer of Clinilabs.

Established seven years ago, Clinilabs has grown to 176 employees. “We started in 2001 with 12 beds and three PK chairs at our first facility in Manhattan, which was located in a remodeled, hospital-owned apartment building. This facility enabled us to take on small but complex studies, and set the stage for our continued focus on integrated PK/PD studies of a complex nature,” Zammit said.

Clinilabs is looking to expand its phase I work outside of New York but wants to be careful with that growth. “We anticipate the expansion of our facilities outside of NYC in the coming months, but we have not yet settled on the location. It is critical for a phase I site to be in an area where there is access to a pool of experienced and talented workers and where there is access to a wide diversity of study participants,” Zammit said.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing